Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373386 · ClinicalTrials.gov registry record · Phase 4
Growth Hormone and Endothelial Function in Children
A Phase 4 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT00373386 is a Phase 4 study that has completed, run by Ohio State University. The registered enrollment target is 9 participants.
The verdict
NCT00373386, a Phase 4 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
Objective: This study is designed to determine whether growth hormone treatment in children 8 to 18 years of age alters function of the lining of the arteries. This may play a role in increasing or decreasing the risk of heart disease. Methods. Twenty children, for whom growth hormone therapy will be otherwise provided, will be studied before and 3 months after starting growth hormone. Subjects can be on other hormonal replacements but no other medications. Each study will be done in the fasting state. The blood vessel function will be determined by measuring the change in forearm blood flow before and after blocking flow to the arm for 5 minutes. Blood will be drawn after the test to measure glucose, insulin and fats.
Interventions
- DRUG growth hormone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00373386
The ClinicalTrials.gov registry entry for NCT00373386 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which growth hormone is the first listed.
NCT00373386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00373386 about?
NCT00373386 is a clinical study titled "Growth Hormone and Endothelial Function in Children". Objective: This study is designed to determine whether growth hormone treatment in children 8 to 18 years of age alters function of the lining of the arteries. This may play a role in increasing or decreasing the risk of heart disease. Methods. Twenty children, for whom growth hormone therapy will ...
What is the current status of trial NCT00373386?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2005-01. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00373386?
The interventions under investigation include: growth hormone (DRUG).
Who is sponsoring clinical trial NCT00373386?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.